| |
|
|
| |
|
 |
 |
¾àǰ°Ë»ö |
 |
ºÎÀÛ¿ë ¹× ´ëó¹ý |
|
|
|
|
|
 |
| |
|
¾ÆÇʸ®ºÎÁÖ40mg/mL(¾ÖÇø®¹ö¼ÁÆ®) 0.278mL Afilivu Inj. 40mg/mL
|
|
Àü¹®ÀǾàǰ | ±Þ¿©
|
|
¼öÀÔÀǾàǰ
|
| |
 |
¾Ë¸²: |
µå·°ÀÎÆ÷¿¡¼´Â ÀǾàǰ ÀÎÅÍ³Ý ÆÇ¸Å¸¦ ÇÏÁö ¾Ê½À´Ï´Ù. |
|
|
|
Àü¹®/ÀÏ¹Ý |
Àü¹®
|
|
|
|
| ¹«»ö ³»Áö ¿¬ÇÑ È²»öÀÇ Åõ¸íÇÑ ¹ÙÀ̾˿¡ µç ÁÖ»çÁ¦ |
|
|
|
|
|
Á¦Á¶È¸»ç |
»ï¼º¹ÙÀÌ¿À¿¡Çǽº(ÁÖ)
|
ÆÇ¸Åȸ»ç |
»ï¼º¹ÙÀÌ¿À¿¡Çǽº(ÁÖ)
|
Çã°¡Á¤º¸ |
Á¤»ó
(2024.02.23)
|
BIT ¾àÈ¿ºÐ·ù |
±âŸ ¾È°ú¿ë¾à(Other Eye Preparations)
|
º¹ÁöºÎºÐ·ù |
439[±âŸÀÇ Á¶Á÷¼¼Æ÷ÀÇ Ä¡·á ¹× Áø´Ü ] |
û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå |
051500121 \298,000 ¿ø/0.278mL/º´(2025.11.01)(ÇöÀç¾à°¡)\350,000 ¿ø/0.278mL/º´(2024.05.01)(º¯°æÀü¾à°¡)
|
|
|
ATCÄÚµå |
aflibercept / S01LA05 |
NDCÄÚµå |
[Proprietary Name Search _ ƯÇãµî·Ï¸í,»óÇ¥¸íÀ¸·Î °Ë»ö]
[Active Ingredient Search _ ÁÖ¼ººÐÀ¸·Î °Ë»ö]
[NDC Number Search _ NDCÄÚµå·Î °Ë»ö]
|
¼ººÐ / ÇÔ·® |
[½ÉÆò¿ø ÁÖ¼ººÐÄÚµå ±âÁØ ¼ººÐÇÔ·®Á¤º¸ Á¶È¸]

|
÷°¡Á¦ |
¸ê±ÕÁÖ»çħ,
¹é´ç,
Àλê¼ö¼ÒÀ̳ªÆ®·ýÀ̼öȹ°,
ÀλêÀ̼ö¼Ò³ªÆ®·ýÀ̼öȹ°,
ÀÏȸ¿ë¿©°ú±âºÎÂøÄ§,
ÁÖ»ç±â,
ÁÖ»ç¿ë¼ö,
Æú¸®¼Ò¸£º£ÀÌÆ®20
|
|
|
|
|
 |
|
|
|
|
|
| Ç× ¸ñ |
³» ¿ë |
|
|
| |
ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2025-10-29 |
|
|
|
|
| |
|
|
|
|